Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Down – Should You Sell?

Anbio Biotechnology (NASDAQ:NNNN)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $14.53, but opened at $13.46. Anbio Biotechnology shares last traded at $14.10, with a volume of 15,742 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, May 14th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the stock has a consensus rating of “Hold”.

Anbio Biotechnology Stock Performance

The stock has a fifty day moving average of $24.60.

Anbio Biotechnology (NASDAQ:NNNN) last announced its quarterly earnings results on Tuesday, April 7th. The company reported $0.03 EPS for the quarter.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.